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Neurons on life support
N
eurons are high maintenance, requiring a continuous supply of nurtur-
ing molecules. A shortage of one of these molecules might underlie one 
of the most common causes of dementia, Van Damme et al. report.
Unlike Alzheimer’s disease, frontotemporal lobe dementia (FTLD) 
usually strikes people who are under the age of 65. Their fatal illness 
devastates the brain’s frontal lobe, causing symptoms such as apathy and 
personality changes, or the temporal lobe, resulting in impaired speech or 
comprehension. Two years ago, researchers showed that some FTLD patients 
carry mutations in the gene for progranulin, a secreted protein that takes part 
in everything from tumor growth to infl  ammation. These glitches often 
reduce mRNA levels, suggesting that the disease stems from insuffi  cient 
progranulin. But researchers knew little about progranulin’s effects on the 
nervous system or how reduced levels could promote brain deterioration.
Van Damme et al. fi  rst determined whether progranulin levels are lower 
in FTLD. Samples of cerebrospinal fl  uid from patients contained much less 
progranulin than did samples from controls. To gauge the impact of this 
reduction, the team cultured rat neurons from the brain and spinal cord. 
Progranulin boosted their survival by up to 39%. After secretion, progranulin 
often gets snipped into multiple pieces, each of which might have a separate 
function. The researchers determined that one of these segments exerted the 
same cell-saving effect as full-sized progranulin. The fi   ndings point to 
progranulin as a potential treatment for FTLD. 
Van Damme, P., et al. 2008. J. Cell Biol. 181:37–41.
Short proteins got no reason to leave
A 
cell uses a simple trick to keep certain proteins from leaving the ER: 
it bars them from the organelle’s exits. Ronchi et al. show how cells 
determine which proteins to keep out.
Proteins due to be exported from the cell 
enter the ER, where they get bundled into 
vesicles that spirit them to the Golgi apparatus. 
One way that the ER prevents its resident 
proteins from departing by the same route 
is to exclude them from exit sites. But re-
searchers didn’t know what characteristics 
get a protein banished. Ronchi et al. sus-
pected that the ER sorts proteins by their 
transmembrane domain (TMD).
To test the idea, the researchers altered 
human cells to manufacture two proteins that 
were identical except for their TMD, which 
was 22 amino acids long in one molecule and 
17 in the other. The team had previously 
shown that the longer protein leaves the ER, while the shorter one stays 
behind. The new work shows that the 17–amino acid protein tended to avoid 
the ER exit sites. The longer protein, however, moved into and out of the 
sites, and a small amount of it accumulated there.
Where each protein ends up might depend on which lipids it associates 
with, the researchers speculate. Because its TMD is longer and more hydro-
phobic, the 22–amino acid version might seek stiffer lipid domains, which 
could gather at the exit sites. The shorter protein, by contrast, would fi  t in better 
with less orderly, thinner portions of the membrane. 
Ronchi, P., et al. 2008. J. Cell Biol. 181:105–118.
Hauling tail
S
olving a long-standing mystery, Altmann 
et al. have discovered that mitochondria 
get around a yeast cell in style. The 
organelles ride on the tail of a myosin molecule 
known as Myo2.
Mitochondria are always on the move. 
They change positions within the cell, come to-
gether to fuse, and split apart. During cell divi-
sion or budding, they migrate into the daughter 
cell. The organelles scoot along actin ﬁ  laments, 
but what powers them has stumped scientists. 
Prime candidates are myosin motors, which 
attach to actin and tow vacuoles and other 
organelles. But the evidence for the myosins’ 
involvement in mitochondrial movement is mixed. 
Yeast strains with mutations in certain myosin 
genes show no abnormalities in mitochondrial 
structure or distribution. However, researchers 
have detected hesitant mitochondria in yeast 
with a mutant form of the myosin Myo2.
To clarify Myo2’s contribution, Altmann 
et al. turned to yeast cells in which the level of 
Myo2 can be reduced by treating the cells with 
the antibiotic, doxycycline. The organelles 
normally link up to form a network. But in cells 
grown with the antibiotic, they clumped or curled 
into rings, suggesting disrupted movement. 
Altmann et al. found that isolated mitochondria 
lacking functional Myo2 cannot bind to actin ﬁ  la-
ments. The team then tested whether Myo2’s tail, 
which carries vacuoles and other organelles, 
also hauls mitochondria. In yeast with mutations 
in the Myo2 tail, the researchers observed mito-
chondrial clumping. When a cell with one of 
these tail mutants sprouted a bud, few mitochon-
dria moved in, Altmann et al. found. They con-
clude that mitochondria travel by boarding 
Myo2’s tail. Up next: determining how Myo2 
attaches to the mitochondrial surface. 
Altmann, K., et al. 2008. J. Cell Biol. 181:119–130.
During budding, glowing mitochondria remain stuck 
in the parent cell if Myo2’s tail is mutated (bottom).
The distributions of proteins 
with a long (red) and short 
(green) transmembrane 
domain don’t overlap.